Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,698.00
Bid: 2,692.00
Ask: 2,694.00
Change: -20.00 (-0.74%)
Spread: 2.00 (0.074%)
Open: 2,722.00
High: 2,732.00
Low: 2,690.00
Prev. Close: 2,718.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Total Voting Rights

3 Nov 2014 07:03

RNS Number : 9397V
Coca-Cola HBC AG
03 November 2014
 



FOR IMMEDIATE RELEASE

Coca-Cola HBC AG

Issue of Equity and Total Voting Rights

 

Zug, Switzerland - 3 November 2014 - Coca-Cola HBC AG ("Coca-Cola HBC") today announces in respect of the month ended 31 October 2014, the issue of 26,526 shares of CHF 6.70 each fully paid ("Ordinary Shares"), following the exercise of options granted under Coca-Cola HBC's share option plan.

 

Such Ordinary Shares were also admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities under Coca-Cola HBC's block listing facility. Following this issue, Coca-Cola HBC has the ability to admit a further 35,356,337 Ordinary Shares under its block listing facility.

 

As at 31 October 2014, Coca-Cola HBC's issued share capital consisted of 367,792,159 Ordinary Shares, of which 14,925 Ordinary shares are held by Coca-Cola HBC AG and 3,430,135 shares are held by its subsidiary, Coca-Cola HBC Services MEPE, in treasury. Accordingly, as at 31 October 2014, the total number of voting rights in Coca-Cola HBC is 364,347,099 for the purposes of the Disclosure and Transparency Rules of the Financial Conduct Authority ("DTRs").

 

Shareholders may use the above total voting rights figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Coca-Cola HBC under the DTRs.

 

This announcement is made in accordance with DTR 5.6.1.

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +41 41 726 0143 basak.kotler@cchellenic.com

 

Eri Tziveli

Investor Relations Manager

Tel: +30 210 618 3133

 eri.tziveli@cchellenic.com

 

Dimitris Bakas

Investor Relations Manager

Tel: +30 210 618 3124

 dimitris.bakas@cchellenic.com

 

About Coca‑Cola HBC

Coca-Cola HBC is the second-largest bottler of the brands of The Coca-Cola Company in terms of volume with sales of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 585 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). Coca-Cola HBC is included in the Dow Jones Sustainability and FTSE4Good Indexes. For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDXLBBZFFBFBB
Date   Source Headline
13th Apr 20182:27 pmRNSNotice of Results
3rd Apr 201810:31 amRNSIssue of equity and total voting rights
19th Mar 20182:54 pmRNSDirector/PDMR Shareholding
16th Mar 20182:41 pmRNSDirector/PDMR Shareholding
16th Mar 20189:07 amRNSAnnual Financial Report
9th Mar 20184:03 pmRNSDirector/PDMR Shareholding
1st Mar 201812:32 pmRNSIssue of equity and total voting rights
27th Feb 20181:05 pmRNSDirector/PDMR Shareholding
26th Feb 20183:33 pmRNSDirector/PDMR Shareholding
23rd Feb 201810:53 amRNSDirector/PDMR Shareholding
22nd Feb 20184:28 pmRNSHolding(s) in Company
22nd Feb 20183:02 pmRNSDirector/PDMR Shareholding
21st Feb 201810:21 amRNSDirector/PDMR Shareholding
21st Feb 201810:13 amRNSDirector/PDMR Shareholding
20th Feb 20182:16 pmRNSDirector/PDMR Shareholding
20th Feb 20181:31 pmRNSDirector/PDMR Shareholding
20th Feb 20181:19 pmRNSDirector/PDMR Shareholding
20th Feb 20181:00 pmRNSDirector/PDMR Shareholding
16th Feb 201811:22 amRNSDirector/PDMR Shareholding
14th Feb 20187:00 amRNSEXCEPTIONAL SET OF RESULTS
1st Feb 201810:35 amRNSIssue of equity and total voting rights
19th Jan 20184:02 pmRNSDirector/PDMR Shareholding
17th Jan 201811:05 amRNSNotice of Results
5th Jan 20184:02 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 201810:04 amRNSIssue of equity and total voting rights
20th Dec 20172:15 pmRNSDirector/PDMR Shareholding
7th Dec 20177:00 amRNSAppointment of Chief Executive Officer
1st Dec 20179:06 amRNSIssue of Equity and Total Voting Rights
20th Nov 201711:57 amRNSDirector/PDMR Shareholding
9th Nov 20177:00 amRNSCONTINUING TO DELIVER EXCELLENT REVENUE GROWTH
1st Nov 20179:07 amRNSIssue of Equity and Total Voting Rights
1st Nov 20178:55 amRNSBlock listing Interim Review
18th Oct 201712:55 pmRNSDirector/PDMR Shareholding
9th Oct 201711:45 amRNSNotice of Results
3rd Oct 20177:00 amRNSStatement re. Chief Executive Officer
2nd Oct 20179:27 amRNSIssue of Equity and Total Voting Rights
27th Sep 201711:13 amRNSDirector Declaration
19th Sep 20173:30 pmRNSDirector/PDMR Shareholding
15th Sep 20177:01 amRNSCEO's medical leave of absence
1st Sep 20179:30 amRNSIssue of Equity and Total Voting Rights
21st Aug 201711:37 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSEXCELLENT FIRST HALF RESULTS
1st Aug 20179:35 amRNSIssue of Equity and Total Voting Rights
28th Jul 20171:02 pmRNSDirector/PDMR Shareholding
19th Jul 20171:51 pmRNSDirector/PDMR Shareholding
4th Jul 201712:56 pmRNSNotice of Results
3rd Jul 20178:16 amRNSIssue of Equity and Total Voting Rights
21st Jun 20179:26 amRNSDirectorate Change
21st Jun 20179:15 amRNSResult of AGM
20th Jun 20173:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.